# Prognostic Significance of lncRNA ATB and SNHG16 Expression Levels in Patients with Hepatocellular Carcinoma

## TL;DR

This study examines the role of two lncRNAs, ATB and SNHG16, in hepatocellular carcinoma and finds no significant link to patient survival or disease features.

## Contribution

The study investigates the prognostic value of ATB and SNHG16 lncRNA expression in hepatocellular carcinoma patients.

## Key findings

- ATB was overexpressed in tumor tissues compared to normal tissues.
- Neither ATB nor SNHG16 overexpression correlated with survival rates or clinicopathological features in HCC patients.

## Abstract

Long noncoding RNAs (lncRNAs) are transcripts longer than 200 nucleotides, a major component of noncoding RNAs. Previous studies have shown the oncogenic role of various lncRNAs. This study aimed to explore the expression and prognostic value of ATB and SNHG16 in patients with hepatocellular carcinoma.

ATB and SNHG16 expression in tumor and adjacent normal tissues was identified using real-time quantitative PCR. In this study, patients were divided into 2 groups based on the expression level of each gene, and the correlation between expression level and clinicopathological features of patients with HCC was investigated. All data were analyzed using SPSS version 22.

Of the lncRNAs examined in this study, ATB was expressed at significantly higher levels in tumor tissues. However, this overexpression was not associated with any clinicopathological features of HCC patients.

In this study, overexpression of ATB and SNHG16 was not associated with survival rate or clinicopathological features of patients with hepatocellular carcinoma.